• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.实验性人类疟疾中的血清细胞因子谱。与攻击后保护和病程的关系。
J Clin Invest. 1992 Aug;90(2):515-23. doi: 10.1172/JCI115889.
2
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.登革病毒感染中T淋巴细胞的激活。登革热患儿血清中高水平的可溶性白细胞介素2受体、可溶性CD4、可溶性CD8、白细胞介素2和干扰素-γ 。
J Clin Invest. 1991 Nov;88(5):1473-80. doi: 10.1172/JCI115457.
3
Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.检测对恶性疟原虫红细胞上抗原产生白细胞介素-4的CD4+CD45RO+T淋巴细胞:减毒恶性疟原虫子孢子诱导的保护性免疫的体外相关指标
Cell Immunol. 1997 Sep 15;180(2):143-52. doi: 10.1006/cimm.1997.1186.
4
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.重组肝期抗原-1(LSA-1)与 AS01 或 AS02 联合使用是安全的,可引发高滴度抗体并诱导 IFN-γ/IL-2 CD4+T 细胞,但不能预防实验性疟原虫感染。
Vaccine. 2010 Jul 12;28(31):5135-44. doi: 10.1016/j.vaccine.2009.08.046. Epub 2009 Sep 6.
5
Frequency of cytokine-producing CD4-CD8- peripheral blood mononuclear cells in patients with Plasmodium falciparum malaria.恶性疟原虫疟疾患者中产生细胞因子的CD4-CD8-外周血单个核细胞的频率
Eur Cytokine Netw. 1999 Jun;10(2):155-60.
6
Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.多种T细胞恶性肿瘤中细胞因子及可溶性细胞因子受体的循环水平
Cancer. 1994 May 1;73(9):2426-31. doi: 10.1002/1097-0142(19940501)73:9<2426::aid-cncr2820730928>3.0.co;2-k.
7
Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者血清中的可溶性CD23及其他受体(CD4、CD8、CD25、CD71)
Leukemia. 1993 Dec;7(12):2019-25.
8
[Changes and significance of TNF, sIL-2R, IL-6, IL-4 and IFN-gamma levels in plasma from the patients with hemorrhagic fever with renal syndrome].[肾综合征出血热患者血浆中肿瘤坏死因子、可溶性白细胞介素-2受体、白细胞介素-6、白细胞介素-4和干扰素-γ水平的变化及意义]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 Nov;20(6):744-6.
9
Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections.恶性疟原虫和间日疟原虫感染的急性期和恢复期细胞因子及血液学参数的变化
Mem Inst Oswaldo Cruz. 2014 Apr;109(2):154-62. doi: 10.1590/0074-0276140275. Epub 2014 Mar 4.
10
Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease.急性恰加斯病患儿血清中细胞因子和可溶性细胞受体的模式
Clin Diagn Lab Immunol. 2002 Nov;9(6):1324-7. doi: 10.1128/cdli.9.6.1324-1327.2002.

引用本文的文献

1
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs.经静脉直接接种疟原虫孢子后人体疟疾感染的安全性、耐受性和寄生虫清除动力学:评估新的血期抗疟药物的模型。
Am J Trop Med Hyg. 2022 Aug 29;107(4):804-814. doi: 10.4269/ajtmh.21-1297. Print 2022 Oct 12.
2
Biomarkers of cellular aging during a controlled human malaria infection.在人为控制的疟疾感染过程中细胞衰老的生物标志物。
Sci Rep. 2021 Sep 21;11(1):18733. doi: 10.1038/s41598-021-97985-y.
3
Mapping immune variation and gene switching in naive hosts infected with .在感染的初始宿主中描绘免疫变异和基因转换。
Elife. 2021 Mar 2;10:e62800. doi: 10.7554/eLife.62800.
4
Molecular characterization and immune protection of an AN1-like zinc finger protein of Eimeria tenella.柔嫩艾美耳球虫 AN1 样锌指蛋白的分子特征及其免疫保护作用。
Parasitol Res. 2020 Feb;119(2):623-635. doi: 10.1007/s00436-019-06545-x. Epub 2019 Nov 22.
5
Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model.快速而激烈与缓慢而平稳:在人体疟疾感染控制模型中对疟原虫的免疫反应的异质性。
Immunol Rev. 2020 Jan;293(1):253-269. doi: 10.1111/imr.12811. Epub 2019 Oct 12.
6
Outcomes of controlled human malaria infection after BCG vaccination.BCG 疫苗接种后控制人体疟疾感染的结果。
Nat Commun. 2019 Feb 20;10(1):874. doi: 10.1038/s41467-019-08659-3.
7
Controlled Human Malaria Infection: Applications, Advances, and Challenges.人体疟疾感染控制:应用、进展与挑战
Infect Immun. 2017 Dec 19;86(1). doi: 10.1128/IAI.00479-17. Print 2018 Jan.
8
Molecular Characterization and Immune Protection of a New Conserved Hypothetical Protein of Eimeria tenella.柔嫩艾美耳球虫一种新的保守假设蛋白的分子特征及免疫保护作用
PLoS One. 2016 Jun 16;11(6):e0157678. doi: 10.1371/journal.pone.0157678. eCollection 2016.
9
Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.慢性血吸虫病对感染曼氏血吸虫和诺氏疟原虫的狒狒的保护作用
Infect Immun. 2016 Apr 22;84(5):1320-1330. doi: 10.1128/IAI.00490-15. Print 2016 May.
10
Live attenuated pre-erythrocytic malaria vaccines.减毒活的红前期疟疾疫苗。
Hum Vaccin Immunother. 2014;10(10):2903-9. doi: 10.4161/21645515.2014.972764.

本文引用的文献

1
Serum C-reactive protein levels and falciparum malaria.血清C反应蛋白水平与恶性疟
Trans R Soc Trop Med Hyg. 1984;78(6):812-3. doi: 10.1016/0035-9203(84)90027-0.
2
Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.急性期蛋白,特别涉及C反应蛋白及相关蛋白(五聚素)和血清淀粉样蛋白A。
Adv Immunol. 1983;34:141-212. doi: 10.1016/s0065-2776(08)60379-x.
3
Spontaneous release of the Leu-2 (T8) molecule from human T cells.人T细胞中Leu-2(T8)分子的自发释放。
J Exp Med. 1983 Sep 1;158(3):752-66. doi: 10.1084/jem.158.3.752.
4
Effect of chloroquine and some other antimalarials on the immune mechanism in experimental animals.
J Pharm Pharmacol. 1984 Apr;36(4):268-9. doi: 10.1111/j.2042-7158.1984.tb04366.x.
5
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.可溶性白细胞介素2受体在体外从活化的人淋巴细胞中释放出来。
J Immunol. 1985 Nov;135(5):3172-7.
6
The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack.
J Interferon Res. 1985 Winter;5(1):169-78. doi: 10.1089/jir.1985.5.169.
7
The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures.
J Interferon Res. 1985 Winter;5(1):159-68. doi: 10.1089/jir.1985.5.159.
8
Interleukin 2 receptor in patients with localized and systemic parasitic diseases.局限性和全身性寄生虫病患者的白细胞介素2受体
Clin Exp Immunol. 1988 May;72(2):249-54.
9
Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.重组干扰素-γ或肿瘤坏死因子对小鼠疟疾(查巴迪疟原虫)的体内抑制作用及其被丁基羟基茴香醚增强的作用。
J Immunol. 1987 Nov 15;139(10):3493-6.
10
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.γ-干扰素对疟原虫红细胞外期发育的抑制作用。
Science. 1986 May 16;232(4752):881-4. doi: 10.1126/science.3085218.

实验性人类疟疾中的血清细胞因子谱。与攻击后保护和病程的关系。

Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

作者信息

Harpaz R, Edelman R, Wasserman S S, Levine M M, Davis J R, Sztein M B

机构信息

Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.

出版信息

J Clin Invest. 1992 Aug;90(2):515-23. doi: 10.1172/JCI115889.

DOI:10.1172/JCI115889
PMID:1644922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC443129/
Abstract

Serum cytokine profiles were evaluated in immunized and nonimmunized human volunteers after challenge with infectious Plasmodium falciparum sporozoites. Three volunteers had been immunized with x-irradiated sporozoites and were fully protected from infection. Four nonimmune volunteers all developed symptomatic infection at which time they were treated. Sera from all volunteers were collected at approximately 20 time points during the 28-d challenge period; levels of IL-1 alpha, IL-1 beta, IL-2, IFN-gamma, tumor necrosis factor-alpha, IL-4, IL-6, granulocyte macrophage-colony-stimulating factor, and soluble CD4, CD8, and IL-2 receptor (sCD4, sCD8, and sIL-2R, respectively) were determined by ELISA. C-reactive protein (CRP) was assayed by radial immunodiffusion. Parasitemic subjects developed increases in CRP and IFN-gamma, with less marked increases in sIL-2R and sCD8; the other cytokines tested did not change. CRP increases were abrupt and occurred at the onset of fever (day 14 after challenge). IFN-gamma increases were also abrupt, preceding those of fever and CRP by one day. Increases in sIL-2R and sCD8 were more gradual. Increases in fever, CRP, IFN-gamma, and sCD8 were concordant in each volunteer. Early IL-6 increases were noted in the protected vaccinees. Thus, after challenge with virulent P. falciparum, unique systemic cytokine profiles were detectable both in immunized, nonparasitemic volunteers and in unvaccinated, parasitemic subjects. The contrasting cytokine profiles in the two groups may relate to mechanisms of protection and immunopathology in experimental human malaria.

摘要

在用感染性恶性疟原虫子孢子攻击免疫和未免疫的人类志愿者后,评估了血清细胞因子谱。三名志愿者用X射线照射的子孢子进行了免疫,并完全受到感染保护。四名非免疫志愿者均出现了有症状的感染,随后接受了治疗。在28天的攻击期内,大约在20个时间点采集了所有志愿者的血清;通过酶联免疫吸附测定法(ELISA)测定白细胞介素-1α(IL-1α)、白细胞介素-1β(IL-1β)、白细胞介素-2(IL-2)、γ-干扰素(IFN-γ)、肿瘤坏死因子-α(TNF-α)、白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、粒细胞巨噬细胞集落刺激因子(GM-CSF)以及可溶性CD4、CD8和白细胞介素-2受体(分别为sCD4、sCD8和sIL-2R)的水平。通过放射免疫扩散法测定C反应蛋白(CRP)。出现疟原虫血症的受试者CRP和IFN-γ升高,sIL-2R和sCD8升高不太明显;所检测的其他细胞因子没有变化。CRP升高是突然的,发生在发热开始时(攻击后第14天)。IFN-γ升高也是突然的,比发热和CRP的升高提前一天。sIL-2R和sCD8的升高较为缓慢。每名志愿者的发热、CRP、IFN-γ和sCD8升高是一致的。在受到保护的接种疫苗者中观察到早期IL-6升高。因此,在用毒性强的恶性疟原虫攻击后,在免疫的、无疟原虫血症的志愿者和未接种疫苗的、有疟原虫血症的受试者中均可检测到独特的全身细胞因子谱。两组中截然不同的细胞因子谱可能与实验性人类疟疾的保护机制和免疫病理学有关。